CELLULES CAR DIRIGÉE CONTRE FLT3 POUR L'IMMUNOTHÉRAPIE
- 专利权人:
- Cytoimmune Therapeutics; LLC
- 发明人:
- 申请号：
- EP16849810.3
- 公开号：
- EP3352784A4
- 申请日:
- 2016.09.23
- 申请国别(地区):
- EP
- 年份:
- 2019
- 代理人:
- 摘要：
- CAR cells targeting FLT3 relevant antigens are described as a new method of cancer treatment. It is proposed that FLT3 CAR cells are safe and effective in patients and can be used to treat human tumors and cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMPOSITIONS ET MÉTHODES D'IMMUNOTHÉRAPIE CIBLANT FLT3, PD-1 ET/OU PD-L1
- Ceramide-Rubusoside Nanomicelles and Their Use in Cancer Therapy
- Composite for delivering a gene into a cell, preparation method thereof, and method of delivering a gene into a cell using same
- COMPOUNDS FOR TREATING BRAIN CANCER
- NOVEL CONJUGATES OF POLYMERS HAVING A THERAPEUTICALLY ACTIVE AGENT AND AN ANGIOGENESIS TARGETING MOIETY ATTACHED THERETO AND USES THEREOF IN THE TREATMENT OF ANGIOGENESIS RELATED DISEASES
